News

AskBio Showcases Key Advances at European Gene Therapy Meeting

AskBio Showcases Key Advances at European Gene Therapy Meeting

AskBio Showcases Key Advances at European Gene Therapy Meeting

Research Triangle Park, N.C. — AskBio Inc., a prominent player in the gene therapy field and a subsidiary of Bayer AG, is gearing up for an influential presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting. With the event set for October in Seville, Spain, AskBio is set to deliver insights regarding their adeno-associated virus (AAV) therapies. This comes as a significant moment in the evolution of gene therapy, advocating for solutions to serious conditions.

Exciting Presentations Highlighting Innovation

This year, AskBio will present six distinct contributions to the scientific community. Among these presentations are one oral and five poster sessions, all designed to emphasize the company's progress in both pipeline development and innovative manufacturing technologies.

CEO Gustavo Pesquin enthusiastically remarked, "The ESGCT meeting provides a unique platform for us to connect with esteemed researchers, clinicians, and industry experts. Here, we can discuss vital advancements and showcase our commitment to operational excellence, ensuring that promising therapies reach those who need them most." Pesquin mentioned the partnership with Viralgen, highlighting their joint presentations that underline clinical achievements and manufacturing advancements.

Oral Presentation to Shine a Light on Delivery Technologies

Among the highlights of the meeting is an oral presentation titled "Delivery Technologies: A Strategic Platform Roadmap for Commercializing Gene Therapy," which is scheduled for October 8. This session, led by Cesar Trigueros from Viralgen, will explore novel methodologies in delivering gene therapies, fostering greater accessibility.

A Range of Posters Showcasing Research

In addition to the oral session, AskBio will present several posters that delve into critical areas of research:

  • Optimized Adenovirus Helper Plasmids for Enhanced Production of Recombinant AAV Vectors - Achille Francois, Wednesday, Oct. 8.
  • Development of Antibody-Escaping AAV Vectors - Carlos Martin de Hijas, Wednesday, October 8.
  • Streamlining Gene Therapy Commercialization - Silvia Gomez, Wednesday, October 8.
  • Precision Treatment of Genetic Diseases - Graham Whyteside, Thursday, October 9.
  • Enhancing AAV Upstream Manufacturing - Itsasne Arangoa, Thursday, October 9.

Transforming Lives with Gene Therapy

AskBio stands at the forefront of gene therapy innovation, with a diverse pipeline targeting debilitating conditions such as congestive heart failure and various muscular dystrophies. Their commitment extends beyond technology to the potential impact on the lives of over 35 million patients battling these diseases globally.

The company has developed a robust platform over recent years, which emphasizes not only scientific advancement but also production efficacy with their proprietary Pro10™ technology. This initiative strives to make gene therapies more accessible and affordable for a wider range of patients.

About AskBio and Its Role in Gene Therapy

As a fully integrated gene therapy company, AskBio takes pride in its independent operation as a subsidiary of Bayer AG. Their focus on gene therapies spans various disorders prevalent in cardiovascular, central nervous system, and neuromuscular health. With a team of over 900 dedicated professionals, they are pioneering advancements while holding a strong portfolio of over 600 patents related to AAV production and therapeutic applications.

The upcoming meetings and presentations are anticipated to be a pivotal moment in showcasing how AskBio continues to push the boundaries of what's possible in gene therapy, fostering hope and improving outcomes for patients across the globe.

Frequently Asked Questions

What is AskBio known for?

AskBio is recognized for its leadership in gene therapy, particularly its development of adeno-associated virus (AAV) therapies aimed at addressing various diseases.

When and where is the European Society of Gene and Cell Therapy meeting?

The ESGCT meeting will take place in October in Seville, Spain, featuring numerous presentations from leading companies in gene therapy.

How does AskBio contribute to gene therapy advancements?

AskBio innovates through contributions to clinical research, novel delivery technologies, and by enhancing manufacturing processes for gene therapies.

What are the major diseases targeted by AskBio's therapies?

Key areas include congestive heart failure, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson's disease, and Pompe disease.

What is the significance of the six presentations at the ESGCT meeting?

The presentations will showcase AskBio's clinical milestones and advancements in gene therapy manufacturing, emphasizing its commitment to improving patient outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tragedy Highlights Need for E-bike Safety Overhaul

Updated Category News Views 5

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 9

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
USPS Rolls Out Christmas Cookie Stamps Nationwide

Updated Category News Views 5

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Continue Reading
Qatar Foundation Spurs Sport-Driven Empowerment Moves

Updated Category News Views 4

Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...

Continue Reading
BarrelPick.com Launches for Bourbon Aficionados

Updated Category News Views 4

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Continue Reading
Papa John's Faces Class Action Over Misleading Info

Updated Category News Views 5

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

Continue Reading
Why Liver Nurture Taps into Health Sector Trends

Updated Category News Views 5

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Continue Reading
Med Spa Visits: Key Insights from Lindsey Smith

Updated Category News Views 4

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 7

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading

Top 5 Most Recently Viewed Articles

Luxfer Holdings Q4 Earnings: A Mixed Bag for Investors

Updated Category News Views 198

The Earnings Rollercoaster Brace yourself—Luxfer Holdings just dropped their Q4 earnings numbers, and it’s a whirlwind of good and not-so-good news. First off, the company beat EPS estimates by a jaw-dropping 21.74%, landing at $0.28 when the street was only expecting $0.23. That’s a solid performance that would normally send stocks soaring, but here we are in the...

Continue Reading
Transforming Business Decisions with SAS Decision Builder

Updated Category News Views 162

SAS Decision Builder Enhances Decision Intelligence on Microsoft Fabric SAS Decision Builder empowers organizations to leverage their data through AI-driven insights and actions that integrate seamlessly into the Microsoft Fabric ecosystem. This cloud-based solution allows businesses to harness the full potential of their data by streamlining the decision-making process....

Continue Reading
Experts Reflect on Economic Impact of Trump's Strategies

Updated Category News Views 199

Reassessing Trump's Economic Policies Amidst changing economic landscapes, several prominent economists, including former advisers to past U.S. presidents, are reevaluating the implications of President-elect Donald Trump's proposed economic measures. Their emerging consensus suggests that Trump's intention to implement broad tariffs, cut taxes, and tighten immigration...

Continue Reading
Quantum Computing Inc. Scores Major Contracts with Industry Giants

Updated Category News Views 182

Quantum Computing Inc. Expands Its Horizons Quantum Computing Inc. QUBT is making waves in the tech industry. By turning complex quantum theories into tangible technologies, the company has secured impressive contracts with a leading U.S. bank, a well-known global automaker, and NASA. This marks a significant leap from theoretical research to practical applications,...

Continue Reading
Compass CEO Robert Reffkin to Address Zelman Housing Summit

Updated Category News Views 226

Compass at the Zelman Housing Summit Compass, Inc. (NYSE: COMP) is gearing up for an exciting event as its CEO and Founder, Robert Reffkin, prepares to speak at the esteemed Zelman Housing Summit. This summit is renowned for uniting the brightest minds in residential real estate to discuss current trends and future opportunities. Insights from Robert Reffkin Robert...

Continue Reading